Catyalyst Pharma (CPRX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $15.13 -1.37%
Revenue Growth %: +16.4%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +16.4%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
